API 0.74% $1.35 australian pharmaceutical industries limited

Ann: Becoming a substantial holder for SIG, page-4

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 421 Posts.
    lightbulb Created with Sketch. 92

    I think this is good news... does anyone know when they trading halt will be lifted? I was looking to buying both API and SIG and now my decision is easy. We just have to sit tight till mid next year and hope the merger goes smoothly. There should be an extra 100million in EBIT (60 million cost saving and 40mllion EBIT from SIG forecast and assuming the SIG part of the business can maintain this level of EBIT post merger for years to come) added over the medium term. The way I see it the merger should just over double market cap of API (current EBIT 80 million) assuming equal PE ratio for the new entity. Ofcourse, API is paying around their own market cap effectively for the merger so I dont expect a huge share price rise. 

    The upside is more than 60 million ebit savings and we because of the larger size of the company, API/SIG can better weather any storms.

 
watchlist Created with Sketch. Add API (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.